The Use of PDX1 DNA Methylation to Distinguish Two Subtypes of Pancreatic Neuroendocrine Neoplasms with Different Prognoses.
Hendrik UngefrorenBjörn KonukiewitzUlrich Friedrich WellnerJörg SchraderTobias KeckPublished in: Cancers (2022)
Pancreatic neuroendocrine neoplasms (pNENs) account for approximately 5% of all pancreatic tumors; thus, they constitute the second most common tumor type in the pancreas [...].